Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 30;21(23):9102.
doi: 10.3390/ijms21239102.

Selective Binding of Cyclodextrins with Leflunomide and Its Pharmacologically Active Metabolite Teriflunomide

Affiliations

Selective Binding of Cyclodextrins with Leflunomide and Its Pharmacologically Active Metabolite Teriflunomide

Irina Terekhova et al. Int J Mol Sci. .

Abstract

The selectivity of encapsulation of leflunomide and teriflunomide by native α-, β- and γ-cyclodextrins was investigated through 1H NMR and molecular modeling. Thermodynamic analysis revealed the main driving forces involved in the binding. For α-cyclodextrin, the partial encapsulation was obtained while deep penetration was characterized for the other two cyclodextrins, where the remaining polar fragment of the molecule is located outside the macrocyclic cavity. The interactions via hydrogen bonding are responsible for high negative enthalpy and entropy changes accompanying the complexation of cyclodextrins with teriflunomide. These results were in agreement with the molecular modeling calculations, which provide a clearer picture of the involved interactions at the atomic level.

Keywords: complex formation; cyclodextrin; leflunomide; molecular modeling; selectivity; teriflunomide.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Structural formulas of leflunomide (a) and teriflunomide (b).
Figure 2
Figure 2
2D 1H NMR ROESY spectra of complexes of CDs with LEF and TEF.
Figure 2
Figure 2
2D 1H NMR ROESY spectra of complexes of CDs with LEF and TEF.
Figure 3
Figure 3
Fragments of 1H NMR spectra of CDs with and without TEF in phosphate buffer (pD 7.4) at 298.15 K.
Figure 3
Figure 3
Fragments of 1H NMR spectra of CDs with and without TEF in phosphate buffer (pD 7.4) at 298.15 K.
Figure 4
Figure 4
Enthalpy–entropy compensation for complex formation of CDs with LEF and TEF at 298.15 K.
Figure 5
Figure 5
Docking results obtained for (A) α-CD/LEF, (B) α-CD/TEF, (C) β-CD/LEF, (D) β-CD/TEF, (E) γ-CD/LEF and (F) γ-CD/TEF. Cyclodextrin core is represented with thin lines and hydrogen bonds with yellow dashes.

Similar articles

Cited by

References

    1. Kaltwasser J.P. Leflunomide in psoriatic arthritis. Autoimmun. Rev. 2007;6:511–514. doi: 10.1016/j.autrev.2006.12.001. - DOI - PubMed
    1. Breedveld F.C., Dayer J.-M. Leflunomide: Mode of action in the treatment of rheumatoid arthritis. Ann. Rheum. Dis. 2000;59:841–849. doi: 10.1136/ard.59.11.841. - DOI - PMC - PubMed
    1. Zhang C., Chu M. Leflunomide: A promising drug with good antitumor potential. Biochem. Biophys. Res. Commun. 2018;496:726–730. doi: 10.1016/j.bbrc.2018.01.107. - DOI - PubMed
    1. Xuan J., Ren Z., Qing T., Couch L., Shi L., Tolleson W.H., Guo L. Mitochondrial dysfunction induced by leflunomide and its active metabolite. Toxicology. 2018;396–397:33–45. doi: 10.1016/j.tox.2018.02.003. - DOI - PMC - PubMed
    1. Warnke C., Stüve O., Kieseiera B.C. Teriflunomide for the treatment of multiple sclerosis. Clin. Neurol. Neurosurg. 2013;115S:511–514. - PubMed

LinkOut - more resources